Show simple item record

dc.contributor.authorBarry, Frank
dc.date.accessioned2009-07-21T16:40:38Z
dc.date.available2009-07-21T16:40:38Z
dc.date.issued2002-10-08
dc.identifier.urihttp://hdl.handle.net/1853/29009
dc.descriptionFrank Barry of Osiris Therapeutics Inc. presented a lecture on October 08, 2002 at 11:00 am in the Suddath Seminar Room, IBB Building, Georgia Tech Campus.en
dc.description.abstractFrank Barry is the Director of Arthritis Research at Osiris Therapeutics, Inc., a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation.en
dc.language.isoen_USen
dc.publisherGeorgia Institute of Technologyen
dc.subjectAdult stem cellsen
dc.subjectOsteoarthritis
dc.subjectRegenerative medicine
dc.subjectMesenchymal stem cells
dc.subjectChondrogen
dc.titleAdult Mesenchymal Stem Cell Therapy in Joint Injury and Diseaseen
dc.title.alternativeAdult Stem Cell Therapy in Joint Disease
dc.typeLectureen
dc.typeVideoen
dc.contributor.corporatenameGeorgia Institute of Technology. Institute for Bioengineering and Bioscience
dc.contributor.corporatenameOsiris Therapeutics


Files in this item

This item appears in the following Collection(s)

Show simple item record